Carglumic acid

Drug Profile

Carglumic acid

Alternative Names: Carbaglu; N-carbamyl-L-glutamic acid

Latest Information Update: 07 Jun 2017

Price : $50

At a glance

  • Originator Orphan Europe
  • Class Glutamates; Small molecules
  • Mechanism of Action Amino-acid-N-acetyltransferase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Acidaemia; Hyperammonaemia
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Hyperammonaemia

Most Recent Events

  • 09 Sep 2015 Registered for Hyperammonaemia in Canada (PO)
  • 03 Jul 2014 Carglumic acid receives Orphan Drug status for Organic acidaemias in USA
  • 06 Jan 2014 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top